003000.KS
Bukwang Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 3,700.00
−1.33%Margins
Gross margin
35.2%
EBITDA margin
7.3%
EBIT margin
5.7%
Net margin
3.7%
FCF margin
5.0%
—
Return on equity
—
Return on assets
—
Return on invested capital
—
Asset turnover
KRW 18.5B
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Sep 1, 2026